Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
AIDS Research and Human Retroviruses|February 17, 2016
Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the CaribbeanAlicen B Spaulding, Qilu Yu, Lucy Civitello, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2012
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infectionPeter L Havens, Kathleen Mulligan, Rohan Hazra, et al.
AIDS (London, England)|June 12, 2010
Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57Yanhua Tang, Sihong Huang, Jacqueline Dunkley-Thompson, et al.
The Lancet. HIV|November 20, 2019
Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort studyPaige L Williams, Cenk Yildirim, Ellen G Chadwick, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2016
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young AdultsKajal B Larson, Tim R Cressey, Ram Yogev, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
AIDS Research and Human Retroviruses|May 29, 2014
Short communication: kidney dysfunction among HIV-infected children in Latin America and the CaribbeanCristina B Hofer, D Robert Harris, Ricardo Hugo de Oliveira, et al.
AIDS (London, England)|March 28, 2014
Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysisSuad Kapetanovic, Ray Griner, Bret Zeldow, et al.
AIDS (London, England)|February 8, 2011
Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapyEllen G Chadwick, Ram Yogev, Carmelita G Alvero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruptionGeorge K Siberry, Kunjal Patel, Russell B Van Dyke, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
AIDS Research and Human Retroviruses|February 17, 2016
Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the CaribbeanAlicen B Spaulding, Qilu Yu, Lucy Civitello, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2012
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infectionPeter L Havens, Kathleen Mulligan, Rohan Hazra, et al.
AIDS (London, England)|June 12, 2010
Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57Yanhua Tang, Sihong Huang, Jacqueline Dunkley-Thompson, et al.
The Lancet. HIV|November 20, 2019
Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort studyPaige L Williams, Cenk Yildirim, Ellen G Chadwick, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2016
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young AdultsKajal B Larson, Tim R Cressey, Ram Yogev, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
AIDS Research and Human Retroviruses|May 29, 2014
Short communication: kidney dysfunction among HIV-infected children in Latin America and the CaribbeanCristina B Hofer, D Robert Harris, Ricardo Hugo de Oliveira, et al.
AIDS (London, England)|March 28, 2014
Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysisSuad Kapetanovic, Ray Griner, Bret Zeldow, et al.
AIDS (London, England)|February 8, 2011
Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapyEllen G Chadwick, Ram Yogev, Carmelita G Alvero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruptionGeorge K Siberry, Kunjal Patel, Russell B Van Dyke, et al.
Pageof 15